Navigation Links
Dolce & Gabbana Ophthalmic Collection

ProductsDolce & Gabbana Ophthalmic Collection
Company Luxottica Group
Item Dolce & Gabbana Ophthalmic Collection
Features Inquire
Description Luxury and professionalism. Glamour and style. Creativity and cutting-edge design. Dolce & Gabbana and Luxottica, two market-leading companies, signed a new licensing agreement in October 2005.The Dolce & Gabbana brand was formed in 1985 by the famous designer duo, Domenico Dolce and Stefano Gabbana, who blended sensuality with their Mediterranean roots to create the distinguishing mark of a brand which has since become a symbol of Italian fashion throughout the world.The first Dolce & Gabbana eyewear collection manufactured by Luxottica drew its inspiration from the fascinating 60s and 70s. This collection brings the periods shapes up to date and highlights its materials, characterized by precious details such as logos in Swarovski crystals or elegant metal circles.
Info Luxottica Group
Customer Service: +39.02.863341
Web site: http://www.luxottica.com/english/index.html

Related medicine products :

1. 2.5V Ophthalmic BETA 200 Pro
2. Katena Ophthalmic Burr
3. Ophthalmic Burr
4. Lpulsa SYL9000 Ophthalmic Yag Laser
5. FML* Ophthalmic Suspension
6. PRED FORTE* Ophthalmic Suspension
7. MAXITROL Ophthalmic Oinent
8. MAXITROL Ophthalmic Suspension
9. CORTISPORIN* Ophthalmic Suspension
10. Hydraulic Ophthalmic Stretcher For Eye Surgery
11. Ophthalmic Surgery Stretcher
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products:
(Date:4/18/2014)... it make you feel? According to psychologists, remembering the ... how sad you were or how embarrassed you felt, ... stop thinking about it. , When these negative ... memories, rather than how you felt, is a relatively ... of these memories, a new study suggests. , Researchers ...
(Date:4/18/2014)... by Northwestern Medicine scientists could lead to potential new ... people with scleroderma. , Fibrosis, or scarring, is ... the skin and lungs can lead to serious organ ... for new therapeutic options centers on findings made by ... identified the role that a specific protein plays in ...
(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... review published in the April issue of Immunity ... Institute for Medical Research, says it,s time to take ... to treating sepsis, which kills millions worldwide every ... when molecules released into the bloodstream to fight an ... is necessary for maintaining good health without inflammation, ...
(Date:4/17/2014)... estimated that as many as 10 million older Americans ... loneliness and isolation. , However, new research a ... older Americans for six years found that Internet ... depression by more than 30 percent. , "That,s a ... University professor of telecommunication, information studies and media who ...
Breaking Medicine News(10 mins):Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New clues on tissue scarring in scleroderma 2Health News:Study recalculates costs of combination vaccines 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Internet use can help ward off depression among elderly 2
... for disease,research got a boost Friday night as Chrysler ... Suwichada presided as honorary chairs for,the Juvenile Diabetes Research ... As part of the evening,s activities, the Jane Jospey ... Ford II. The award is given each year,to individuals ...
... Women to ,Speak Up For Down There, During National ... ... Despite living in a society,that promotes images and icons of female ... Sue Johannsen and even,former Supreme Court Justice Sandra Day O,Conner, more ...
... tough. The good news: it gets better. , A ... its graduates (ages 20-29 years old) tracked mental health ... at how key events like leaving home and becoming ... showed a significant decrease in depressive symptoms over the ...
... May 13, 2008 The American Society ... control guidelines regarding gastrointestinal (GI) endoscopy. The guidelines ... event since the adoption of endoscope reprocessing (cleaning) ... the May issue of GIE: Gastrointestinal Endoscopy, the ...
... division is essential to life, but the mechanism by ... genetic endowments is little understood. In a new study, ... report on how a key motor protein orchestrates chromosome ... The study appeared in the Proceedings of the National ...
... of childhood,obesity in America has more than tripled ... ages 10 to 17 are overweight or obese(2).,Compelled ... obesity epidemic for,children, families, communities and the health ... ( http://www.bluefoundationfl.com ), the,philanthropic affiliate of Blue Cross ...
Cached Medicine News:Health News:Chrysler LLC Vice Chairman and President Jim Press and His Wife Suwichada Serve as Honorary Co-Chairs of Annual Juvenile Diabetes Research Foundation Promise Ball 2Health News:Study Finds More Than One in Two Women are Too Embarrassed to Discuss Vaginal Discomfort With Their Doctors 2Health News:Study Finds More Than One in Two Women are Too Embarrassed to Discuss Vaginal Discomfort With Their Doctors 3Health News:Study Finds More Than One in Two Women are Too Embarrassed to Discuss Vaginal Discomfort With Their Doctors 4Health News:Depression and anger can plague recent university graduates: Study 2Health News:ASGE issues updated infection control guidelines for gastrointestinal endoscopy 2Health News:ASGE issues updated infection control guidelines for gastrointestinal endoscopy 3Health News:Research shines spotlight on a key player in the dance of chromosomes 2Health News:Research shines spotlight on a key player in the dance of chromosomes 3Health News:The Blue Foundation for a Healthy Florida Announces $8 Million Initiative to Address Childhood Obesity 2
(Date:1/15/2014)... Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... tender offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary ... common stock of Solta Medical, Inc. (NASDAQ: ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... 14, 2014  Luminex Corporation (Nasdaq: LMNX ) today ... quarter of 2013 on Monday, February 3, 2014. A press ... close of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... the operating highlights and financial results for the fourth quarter ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3